Search Results - "IANNITTO, Emilio"
-
1
How I diagnose and treat splenic lymphomas
Published in Blood (03-03-2011)“…The incidental finding of an isolated splenomegaly during clinical assessment of patients evaluated for unrelated causes has become increasingly frequent…”
Get full text
Journal Article -
2
Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle
Published in Frontiers in immunology (23-08-2023)“…We have established a pseudotemporal ordering for the transcriptional signatures of distinct microregions within reactive lymphoid tissues, namely germinal…”
Get full text
Journal Article -
3
Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
Published in Journal of clinical oncology (20-08-2007)“…Starting from November 2001, 260 newly diagnosed patients with Hodgkin's lymphoma (HL) were consecutively enrolled in parallel Italian and Danish prospective…”
Get full text
Journal Article -
4
Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients
Published in Mayo Clinic proceedings (01-06-2015)“…Abstract Objective To verify whether absolute monocyte count (AMC) and lymphocyte- monocyte ratio (LMR) at diagnosis are valid prognostic parameters in…”
Get full text
Journal Article -
5
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
Published in Journal of clinical oncology (10-02-2009)“…To compare doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) versus bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and…”
Get full text
Journal Article -
6
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
Published in Haematologica (Roma) (14-03-2024)Get full text
Journal Article -
7
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
Published in Cancer medicine (Malden, MA) (01-09-2020)“…Purpose We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin),…”
Get full text
Journal Article -
8
Splenic marginal zone lymphoma
Published in Blood (01-04-2003)“…Splenic marginal zone lymphoma (SMZL) is a specific low-grade small B-cell lymphoma that is incorporated in the World Health Organization classification…”
Get full text
Journal Article -
9
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study
Published in Blood (01-08-2003)“…The existence of an association between infection with hepatitis C virus (HCV) and B-cell non-Hodgkin lymphoma (B-NHL) remains controversial, largely because…”
Get full text
Journal Article -
10
Splenic lymphangiomatosis showing rapid growth during lactation: a case report
Published in World journal of gastroenterology : WJG (07-03-2010)“…Splenic lymphangiomatosis is a very rare condition that, from 1990 to date, has been described only nine times. In the present report, we describe the first…”
Get full text
Journal Article -
11
Advanced mast cell disease: an Italian Hematological Multicenter experience
Published in International journal of hematology (01-12-2008)“…The aim of the study is to evaluate clinical features, treatments and outcome of patients with systemic mast cell disease (MCD) who arrived to the attention of…”
Get full text
Journal Article -
12
Paroxysmal nocturnal hemoglobinuria: When delay in diagnosis and long therapy occurs
Published in Hematology reports (29-03-2018)“…Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disorder characterized by hemolytic anemia, bone marrow failure and thrombosis, caused by a somatic…”
Get full text
Journal Article -
13
Hepatitis B virus reactivation and alemtuzumab therapy
Published in European journal of haematology (01-03-2005)“…: Reactivation of hepatitis B virus infection in subjects receiving cytotoxic treatment for heamatological malignancies occurs in 21–53% of chronic HBsAg…”
Get full text
Journal Article -
14
CD146+ bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis
Published in Haematologica (Roma) (01-01-2009)“…1 Department of Human Pathology, Paolo Giaccone University Hospital, University of Palermo, Palermo 2 Pathology Unit, Department of Medicine, Surgery and…”
Get full text
Journal Article -
15
Two Cases of Q-Fever in Hairy Cell Leukemia
Published in Case reports in hematology (01-01-2014)“…Hairy cell leukemia (HCL) is a rare B-cell lymphoproliferative disorder accounting for about 2% of all leukemias. The clinical course is indolent, however HCL…”
Get full text
Journal Article -
16
MOPPEBVCAD Chemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin's Lymphoma: 10-Year Results, Late Toxicity, and Second Tumors
Published in Clinical cancer research (15-01-2006)“…Purpose: MOPPEBVCAD (mechlorethamine, vincristine, procarbazine, prednisone, epidoxirubicin, bleomycin, vinblastine, lomustine, doxorubicin, and vindesine)…”
Get full text
Journal Article -
17
A rapidly progressive motor neuron disease associated to a natural killer cells leukaemia
Published in Journal of the neurological sciences (15-03-2019)Get full text
Journal Article -
18
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Published in Blood (01-10-2007)“…To evaluate in a prospective multicenter trial the feasibility and clinical efficacy of the combination of alemtuzumab (Campath-1H) with the…”
Get full text
Journal Article -
19
Gamma-delta T-cell lymphomas
Published in Nature reviews. Clinical oncology (01-12-2009)“…Gamma-delta lymphomas are rare and aggressive lymphomas with a poor prognosis. The authors of this Review discuss the clinical and biological features of the…”
Get full text
Journal Article -
20
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
Published in Annals of oncology (01-03-2013)“…To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferences to better clarify open issues in each disease. In this…”
Get full text
Journal Article Conference Proceeding